Moneycontrol
    Moneycontrol PRO
    FiDEX 2026
    FiDEX 2026

    Lupin Q1 PAT seen up 27% to Rs 267 cr

    Drug producer Lupin's profit after tax is likely to grow by 27% year-on-year and 71.6% quarter-on-quarter to Rs 267 crore in the quarter ended June 2012.

    July 24, 2012 / 14:15 IST

    Drug producer Lupin's profit after tax is likely to grow by 27% year-on-year and 71.6% quarter-on-quarter to Rs 267 crore in the quarter ended June 2012.

    One of expenses on litigation & forex losses were impacted profit after tax of fourth quarter of last financial year 2011-12.

    Revenues are seen going up by 29% YoY and 5.3% QoQ to Rs 2,026 crore during the same period. Earnings before interest, tax, depreciation and amortisation (EBITDA) are expected to increase by 35.7% YoY and 7% QoQ to Rs 399.5 crore in the June quarter.

    Operating profit margin is likely to be at 19.7% in the April-June quarter as against 18.8% in a year ago period and 19.4% in the previous quarter.

    first published: Jul 24, 2012 10:14 am

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
    CloseParallel Income Plan 2026